Matthias J Schnell

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 23

Top Venues

Thomas Jefferson University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Thomas Jefferson University

United States

Professor and Chair :: Microbiology and Immunolgy

Publications

Gabrielle Scher, Catherine Yankowski, Drishya Kurup, Nicole M Josleyn, Eric R Wilkinson, Jay Wells, Jesse Steffens, Ginger Lynn, Sean Vantongeren, Xiankun Zeng, Nancy Twenhafel, Kathleen A Cashman, Matthias J Schnell
Inactivated rabies-based Lassa fever virus vaccine candidate LASSARAB protects nonhuman primates from lethal disease. NPJ vaccines 9 (1) (2024)
Sabrine Ben Hamed, Jacob F Myers, Anisha Chandwani, Christoph Wirblich, Drishya Kurup, Nir Paran, Matthias J Schnell
Toward the Development of a Pan-Lyssavirus Vaccine. Viruses 16 (7) (2024)
Gabrielle Scher, Catherine Yankowski, Drishya Kurup, Nicole M Josleyn, Eric R Wilkinson, Jay Wells, Jesse Steffens, Ginger Lynn, Sean Vantongeren, Xiankun Zeng, Nancy Twenhafel, Kathleen A Cashman, Matthias J Schnell
Inactivated rabies-based Lassa fever virus vaccine candidate LASSARAB protects nonhuman primates from lethal disease. NPJ vaccines 9 (1) (2024)
Sabrine Ben Hamed, Jacob F Myers, Anisha Chandwani, Christoph Wirblich, Drishya Kurup, Nir Paran, Matthias J Schnell
Toward the Development of a Pan-Lyssavirus Vaccine. Viruses 16 (7) (2024)
Sabrine Ben Hamed, Jacob F Myers, Anisha Chandwani, Christoph Wirblich, Drishya Kurup, Nir Paran, Matthias J Schnell
Toward the Development of a Pan-Lyssavirus Vaccine. Viruses 16 (7) (2024)
Gabrielle Scher, Catherine Yankowski, Drishya Kurup, Nicole M Josleyn, Eric R Wilkinson, Jay Wells, Jesse Steffens, Ginger Lynn, Sean Vantongeren, Xiankun Zeng, Nancy Twenhafel, Kathleen A Cashman, Matthias J Schnell
Inactivated rabies-based Lassa fever virus vaccine candidate LASSARAB protects nonhuman primates from lethal disease. NPJ vaccines 9 (1) (2024)
Catherine Yankowski, Drishya Kurup, Christoph Wirblich, Matthias J Schnell
Effects of adjuvants in a rabies-vectored Ebola virus vaccine on protection from surrogate challenge. NPJ vaccines 8 (1) (2023)
Catherine Yankowski, Drishya Kurup, Christoph Wirblich, Matthias J Schnell
Effects of adjuvants in a rabies-vectored Ebola virus vaccine on protection from surrogate challenge. NPJ vaccines 8 (1) (2023)
Gabrielle Scher, Dennis A Bente, Megan C Mears, Maria N B Cajimat, Matthias J Schnell
GP38 as a vaccine target for Crimean-Congo hemorrhagic fever virus. NPJ vaccines 8 (1) (2023)
Catherine Yankowski, Drishya Kurup, Christoph Wirblich, Matthias J Schnell
Effects of adjuvants in a rabies-vectored Ebola virus vaccine on protection from surrogate challenge. NPJ vaccines 8 (1) (2023)
Gabrielle Scher, Dennis A Bente, Megan C Mears, Maria N B Cajimat, Matthias J Schnell
GP38 as a vaccine target for Crimean-Congo hemorrhagic fever virus. NPJ vaccines 8 (1) (2023)
Gabrielle Scher, Dennis A Bente, Megan C Mears, Maria N B Cajimat, Matthias J Schnell
GP38 as a vaccine target for Crimean-Congo hemorrhagic fever virus. NPJ vaccines 8 (1) (2023)
Drishya Kurup, Christoph Wirblich, Rachael Lambert, Leila Zabihi Diba, Benjamin E Leiby, Matthias J Schnell
Measles-based Zika vaccine induces long-term immunity and requires NS1 antibodies to protect the female reproductive tract. NPJ vaccines 7 (1) (2022)
Catherine Yankowski, Christoph Wirblich, Drishya Kurup, Matthias J Schnell
Inactivated rabies-vectored SARS-CoV-2 vaccine provides long-term immune response unaffected by vector immunity. NPJ vaccines 7 (1) (2022)
Drishya Kurup, Christine R Fisher, Gabrielle Scher, Catherine Yankowski, AnnaMarie Testa, Rohan Keshwara, Tiago Abreu-Mota, Rachael Lambert, Melissa Ferguson, William Rinaldi, Leonard Ruiz, Christoph Wirblich, Matthias J Schnell
Tetravalent Rabies-Vectored Filovirus and Lassa Fever Vaccine Induces Long-term Immunity in Nonhuman Primates. The Journal of infectious diseases 224 (6) (2022)
Delphine C Malherbe, Drishya Kurup, Christoph Wirblich, Adam J Ronk, Chad E Mire, Natalia Kuzmina, Noor Shaik, Sivakumar Periasamy, Matthew A Hyde, Julie M Williams, Pei-Yong Shi, Matthias J Schnell, Alexander Bukreyev
A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19. NPJ vaccines 6 (1) (2021)
Drishya Kurup, Delphine C Malherbe, Christoph Wirblich, Rachael Lambert, Adam J Ronk, Leila Zabihi Diba, Alexander Bukreyev, Matthias J Schnell
Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster model. PLoS pathogens 17 (3) (2021)
Drishya Kurup, Christoph Wirblich, Holly Ramage, Matthias J Schnell
Rabies virus-based COVID-19 vaccine CORAVAX™ induces high levels of neutralizing antibodies against SARS-CoV-2. NPJ vaccines 5 (2020)
Venice Du Pont, Christoph Wirblich, Jeong-Joong Yoon, Robert M Cox, Matthias J Schnell, Richard K Plemper
Identification and Characterization of a Small-Molecule Rabies Virus Entry Inhibitor. Journal of virology 94 (13) (2020)
Rohan Keshwara, Katie R Hagen, Tiago Abreu-Mota, Amy B Papaneri, David Liu, Christoph Wirblich, Reed F Johnson, Matthias J Schnell
A Recombinant Rabies Virus Expressing the Marburg Virus Glycoprotein Is Dependent upon Antibody-Mediated Cellular Cytotoxicity for Protection against Marburg Virus Disease in a Murine Model. Journal of virology 93 (6) (2019)
Christoph Wirblich, Christopher M Coleman, Drishya Kurup, Tara S Abraham, John G Bernbaum, Peter B Jahrling, Lisa E Hensley, Reed F Johnson, Matthew B Frieman, Matthias J Schnell
One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus. Journal of virology 91 (2) (2017)
Benjamin M Davis, Volker Fensterl, Tessa M Lawrence, Andrew W Hudacek, Ganes C Sen, Matthias J Schnell
Ifit2 Is a Restriction Factor in Rabies Virus Pathogenicity. Journal of virology 91 (17) (2017)
Renata da Fontoura Budaszewski, Andrew Hudacek, Bevan Sawatsky, Beate Krämer, Xiangping Yin, Matthias J Schnell, Veronika von Messling
Inactivated Recombinant Rabies Viruses Displaying Canine Distemper Virus Glycoproteins Induce Protective Immunity against Both Pathogens. Journal of virology 91 (8) (2017)
Drishya Kurup, Christoph Wirblich, Heinz Feldmann, Andrea Marzi, Matthias J Schnell
Rhabdovirus-based vaccine platforms against henipaviruses. Journal of virology 89 (1) (2014)

Matthias J Schnell.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Matthias J Schnell